BusinessXBiotech to Present Pivotal Phase 3 Data on Xilonix™ at European Society of Medical Oncology’s World Congress on Gastrointestinal CancerBy Nasdaq OMXApr 19, 2016, 12:00 PM UTC
BusinessMelinta Therapeutics Appoints Dr. Eugene Sun as Chief Executive OfficerBy Nasdaq OMXApr 19, 2016, 12:00 PM UTC
BusinessInnate Pharma presents new CD73 checkpoint inhibitor programBy Nasdaq OMXApr 18, 2016, 6:14 PM UTC
BusinessCyclacel’s Second-Generation CDK2/9 Inhibitor, CYC065, is an Effective Inducer of Cell Death in B-cell Lymphoma and Synergizes With Bcl-2 or BET InhibitorsBy Nasdaq OMXApr 18, 2016, 1:00 PM UTC
BusinessFibrocell and Intrexon Announce Allowance to Commence Phase I/II Trial for FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)By Nasdaq OMXApr 18, 2016, 12:00 PM UTC
BusinessMerus to Present Interim Clinical Data from Ongoing Phase 1/2 Clinical Trial of its Lead Bispecific Antibody Candidate, MCLA-128, at the American Association for Cancer Research 2016 Annual MeetingBy Nasdaq OMXApr 15, 2016, 9:06 PM UTC
BusinessLifeSci Advisors Announces Comprehensive Action Plan to Advance Gender Diversity in the Life Sciences IndustryBy Nasdaq OMXApr 15, 2016, 5:54 PM UTC
BusinessNewLink Genetics Receives $2.8 Million Award from DTRA to Develop a Multivalent Filovirus VaccineBy Nasdaq OMXApr 15, 2016, 11:00 AM UTC
